Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

INTRODUCTION: Direct oral anticoagulants (DOAC) have gained an increased share over warfarin for prevention and treatment of thromboembolic disease. We studied DOAC adoption across providers and medical specialties. METHODS: Retrospective, cross-sectional analysis of Medicare Part D public use files...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziakas, Panayiotis D., Kourbeti, Irene S., Poulou, Loukia S., Vlachogeorgos, Georgios S., Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991647/
https://www.ncbi.nlm.nih.gov/pubmed/29879194
http://dx.doi.org/10.1371/journal.pone.0198674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991647/
https://www.ncbi.nlm.nih.gov/pubmed/29879194
http://dx.doi.org/10.1371/journal.pone.0198674

Ejemplares similares